Zhifeng Ning
Xianning, 437100, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Trends in food protein-induced allergic proctocolitis (FPIAP): Mechanisms and treatment targeting gut microbiome.
Journal: Clinics and research in hepatology and gastroenterology
Published: December 27, 2024
Antitumor properties of griseofulvin and its toxicity.
Journal: Frontiers in pharmacology
Published: July 04, 2024
Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review).
Journal: Experimental and therapeutic medicine
Published: June 13, 2023
Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers.
Journal: Frontiers in oncology
Published: March 10, 2023
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors.
Journal: Frontiers in oncology
Published: August 25, 2022
Noncoding RNAs and Virus and Treatment in Allergic Rhinitis.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 01, 2022
PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway.
Journal: Frontiers in oncology
Published: March 21, 2019
Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis.
Journal: Cancer letters
Published: December 04, 2018
Cancer stem cells in esophageal squamous cell cancer.
Journal: Oncology letters
Published: August 30, 2018
Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway.
Journal: Journal of thoracic disease
Published: August 03, 2018
Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis.
Journal: Journal of breast cancer
Published: November 14, 2017
Last Updated: 09/26/2026